ArticleCureus2026
Olfactory Hallucinations as the Initial Symptom of Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: A Case Report and Review of the Literature.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-leucine-rich glioma-inactivated 1 (LGI-1) antibody encephalitis is an autoimmune encephalitis mediated by LGI-1 antibodies that target proteins on the surface of neuronal cell membranes. Its clinical manifestations are diverse, but olfactory hallucinations rarely present as the initial symptom. We report the case of a 61-year-old man who initially presented with olfactory hallucinations and abdominal discomfort lasting six months. This was rapidly followed by memory impairment, twitching at the right corner of the mouth, and upper limb spasms. A follow-up brain MRI scan revealed abnormal signals in the bilateral hippocampi, and both serum and cerebrospinal fluid (CSF) tests were positive for LGI-1 antibodies, leading to a diagnosis of anti-LGI-1 antibody-associated encephalitis. Following high-dose steroid pulse therapy, the patient achieved complete remission of symptoms. This report suggests that olfactory hallucinations may be an early manifestation of the disease involving the parahippocampal gyrus and the uncus. In middle-aged men presenting with new-onset olfactory hallucinations or similar symptoms, antibody screening should be performed as early as possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.